Latest evidence-based view
AVEM · HOLD
AVEM (Avantis Emerging Markets Equity) packages one region's currency, policy and sector mix. One-month (+10.31%) and three-month (-2.29%) evidence is not decisive enough for a directional call.
AVEM currently supports a wait stance.
One-month (+10.31%) and three-month (-2.29%) evidence is not decisive enough for a directional call.
The opposing case is clear: political, currency and sector concentration can cluster losses. the 0.33% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.
Use staged sizing and reassess when the one- and three-month trends no longer support this stance.